The GVT effect has shown significant efficacy in hematologic malignancies, such as leukemia, lymphoma, and multiple myeloma. It has been particularly effective in treating chronic myeloid leukemia (CML). However, its effectiveness in solid tumors like breast cancer, lung cancer, and gastrointestinal cancers is still under investigation and less pronounced compared to hematologic cancers.
